Kuala Lumpur, 5 May 2020: Nexgram Industries Sdn Bhd has been appointed as the authorised distributor of antibody IgM/IgG Covid-19 diagnostic kit in Malaysia and Indonesia by Shanghai Liangrun Biomedicine Technology Co Ltd since April 3 2020.
Nexgram Industries is a wholly-owned subsidiary of Nexgram Holdings Bhd (NEXGRAM).
Nexgram Industries had also submitted an application to the Ministry of Health for the certification of the diagnostic kit and is currently pending approval.
“Further, Nexgram Industries had also on May 5 appointed Tri-G Technologies Sdn Bhd as the sub-distributor for the distribution of the diagnostic kit,” NEXGRAM said.
Shanghai Liangrun is a company principally engaged in biomedicine technology, while TRI-G is the licensed medical device distributor in Malaysia in collaboration with a network of more than 5,000 medical providers nationwide.
TRI-G is a licensed medical device distributor and had obtained Malaysia master authorisation to distribute Novel Coronavirus (2019-nCoV) IgM/IgG Rapid Test Kit, and Novel Coronavirus (2019-nCoV) RT-qPCR Detection and Diagnostic Kit. TRI-G is currently already distributing Malaysia Medical Device Authority (MDA) special access approved Novel Coronavirus (2019-nCoV) IgM/IgG Rapid Test Kit to medical centres right after 18 March 2020 the start of movement control order (MCO).
“Nexgram have local presence in Malaysia, Thailand, Indonesia, Vietnam, and Philippines. Our local representatives are working closely with health authorities in South East Asia countries to obtain the relevant approval for the use of our medical test kits,” added Haji Mazru, Executive Director of NEXGRAM.
ABOUT NEXGRAM HOLDINGS BHD
NEXGRAM HOLDINGS BERHAD is listed on the ACE Market of Bursa Malaysia Exchange and its headquarter is in Malaysia. The group is a diversified investment company having businesses in IT, security and surveillance, logistics, property and other industries.
ABOUT TRI-G TECHNOLOGIES SDN BHD
TRI-G is a MDA licensed medical supplies distributor with GDPMD certificate in Malaysia. The company is in collaboration with a network of more than 5,000 medical providers nationwide.
Nexgram Covid-19 AID Team (NCA)